Loading stock data…
Elanco Animal Health Incorporated (ELAN)
$24.74+0.17 (+0.69%)
Market ClosedLast close Jun 29
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Elanco Animal Health Incorporated in the Healthcare sector is trading at $24.74 with a market capitalization of $11.9B. Wall Street consensus targets $29.86 (14 analysts), implying a +20.7% move over the next 12 months. The stock is currently 11% below its 52-week high of $27.72, remaining 8.6% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +20.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.37B↑ | $1.14B↑ | $1.14B↓ | $1.24B↑ | $1.19B |
| Gross Profit | $785.00M↑ | $589.00M↓ | $607.00M↓ | $713.00M↑ | $684.00M |
| Operating Income | $169.00M↑ | $19.00M↓ | $27.00M↓ | $85.00M↓ | $121.00M |
| Net Income | $57.00M↑ | -$276.00M↓ | -$34.00M↓ | $11.00M↓ | $67.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that p...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.92B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-3.72%
Volume
Today's trading volume
3.10M
Recent News
Is Elanco Animal Health Incorporated (ELAN) Positioned for Long-Term Growth With Seven Potential Blockbuster Launches?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Elanco Animal Health Incorporated (NYSE:ELAN) is among the best healthcare stocks. TheFly reported on June 18 that TD Cowen analyst Steve Scala increased the price target on ELAN to $32 from $31 while maintaining a Buy rating […]
1 Mid-Cap Stock to Own for Decades and 2 We Question
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
1 Profitable Stock to Target This Week and 2 We Avoid
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
2 Cash-Producing Stocks on Our Buy List and 1 That Underwhelm
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Is It Too Late To Consider Elanco Animal Health (ELAN) After Its Strong 1 Year Rally?
Wondering if Elanco Animal Health stock still offers value at around US$24.71, or if the easy money has already been made. The stock has returned 3.0% over the past week, 7.5% over the past month and 9.7% year to date, with an 84.0% return over the past year and 164.3% over three years, while the five year period shows a decline of 26.4%. Recent attention around Elanco Animal Health has focused on how the stock's strong 1 year and 3 year performance lines up with its fundamentals and balance...